You just read:

Amygdala Neurosciences and NIAAA will Conduct a Phase 2 Clinical study of ANS-6637 for the Treatment of Alcohol Use Disorder

News provided by

Amygdala Neurosciences

Sep 12, 2018, 09:47 ET